Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
31516 | 152 | 18.5 | 58% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
11 | 3 | ATRIAL FIBRILLATION//CARDIAC & CARDIOVASCULAR SYSTEM//CATHETER ABLATION | 130936 |
2637 | 2 | IVABRADINE//SINOATRIAL NODE//HCN CHANNELS | 3514 |
31516 | 1 | SALVICINE//DIPFLUZINE//DIPFLUZINE HYDROCHLORIDE | 152 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SALVICINE | authKW | 1808018 | 8% | 75% | 12 |
2 | DIPFLUZINE | authKW | 1168819 | 5% | 73% | 8 |
3 | DIPFLUZINE HYDROCHLORIDE | authKW | 602675 | 2% | 100% | 3 |
4 | META NISOLDIPINE | authKW | 602675 | 2% | 100% | 3 |
5 | STATE DRUG PHYTOCHEM | address | 602675 | 2% | 100% | 3 |
6 | STATE DRUG ANTITUMOR PHARMACOL | address | 418518 | 3% | 42% | 5 |
7 | GUANFU BASE A HYDROCHLORIDE | authKW | 401783 | 1% | 100% | 2 |
8 | M NISOLDIPINE | authKW | 358729 | 3% | 36% | 5 |
9 | GUANFU BASE A | authKW | 258286 | 2% | 43% | 3 |
10 | PHARMACOL TOXICOL NEW DRUG | address | 225999 | 2% | 38% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1791 | 63% | 0% | 95 |
2 | Chemistry, Multidisciplinary | 746 | 45% | 0% | 69 |
3 | Biophysics | 55 | 8% | 0% | 12 |
4 | Oncology | 24 | 9% | 0% | 13 |
5 | Cardiac & Cardiovascular System | 15 | 5% | 0% | 8 |
6 | Peripheral Vascular Diseases | 11 | 3% | 0% | 5 |
7 | Cell Biology | 8 | 6% | 0% | 9 |
8 | Medicine, Research & Experimental | 5 | 3% | 0% | 5 |
9 | Medicine, Legal | 4 | 1% | 0% | 1 |
10 | Integrative & Complementary Medicine | 3 | 1% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | STATE DRUG PHYTOCHEM | 602675 | 2% | 100% | 3 |
2 | STATE DRUG ANTITUMOR PHARMACOL | 418518 | 3% | 42% | 5 |
3 | PHARMACOL TOXICOL NEW DRUG | 225999 | 2% | 38% | 3 |
4 | ANTITUMOR PPHARMACOL | 200892 | 1% | 100% | 1 |
5 | COMBINAT TRADIT CHINESE MED WESTERN MED | 200892 | 1% | 100% | 1 |
6 | DISCIPLINA BIOFISCCBS | 200892 | 1% | 100% | 1 |
7 | IMIB UMUMURCIA BIOHEALTH MED | 200892 | 1% | 100% | 1 |
8 | INFORMAT SIMULAT DESIGN | 200892 | 1% | 100% | 1 |
9 | XIANNING BRANCH PHARMACOL | 200892 | 1% | 100% | 1 |
10 | ANTITUMOR PHARMACOL | 42600 | 5% | 3% | 7 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ACTA PHARMACOLOGICA SINICA | 146445 | 42% | 1% | 64 |
2 | BIOFIZIKA | 1724 | 4% | 0% | 6 |
3 | KARDIOLOGIYA | 1100 | 4% | 0% | 6 |
4 | JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION | 557 | 2% | 0% | 3 |
5 | INTERNATIONAL JOURNAL OF MEDICINAL MUSHROOMS | 346 | 1% | 0% | 1 |
6 | PHYSIOLOGIA BOHEMOSLOVACA | 293 | 1% | 0% | 1 |
7 | PHARMACOLOGY | 242 | 1% | 0% | 2 |
8 | PHARMACOLOGICAL RESEARCH COMMUNICATIONS | 218 | 1% | 0% | 1 |
9 | REDOX REPORT | 213 | 1% | 0% | 1 |
10 | EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS | 129 | 1% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SALVICINE | 1808018 | 8% | 75% | 12 | Search SALVICINE | Search SALVICINE |
2 | DIPFLUZINE | 1168819 | 5% | 73% | 8 | Search DIPFLUZINE | Search DIPFLUZINE |
3 | DIPFLUZINE HYDROCHLORIDE | 602675 | 2% | 100% | 3 | Search DIPFLUZINE+HYDROCHLORIDE | Search DIPFLUZINE+HYDROCHLORIDE |
4 | META NISOLDIPINE | 602675 | 2% | 100% | 3 | Search META+NISOLDIPINE | Search META+NISOLDIPINE |
5 | GUANFU BASE A HYDROCHLORIDE | 401783 | 1% | 100% | 2 | Search GUANFU+BASE+A+HYDROCHLORIDE | Search GUANFU+BASE+A+HYDROCHLORIDE |
6 | M NISOLDIPINE | 358729 | 3% | 36% | 5 | Search M+NISOLDIPINE | Search M+NISOLDIPINE |
7 | GUANFU BASE A | 258286 | 2% | 43% | 3 | Search GUANFU+BASE+A | Search GUANFU+BASE+A |
8 | 2 P DIMETHYLAMINO STYRYLPYRIDINE METHIODIDE | 200892 | 1% | 100% | 1 | Search 2+P+DIMETHYLAMINO+STYRYLPYRIDINE+METHIODIDE | Search 2+P+DIMETHYLAMINO+STYRYLPYRIDINE+METHIODIDE |
9 | A549 SAL CELL LINE | 200892 | 1% | 100% | 1 | Search A549+SAL+CELL+LINE | Search A549+SAL+CELL+LINE |
10 | ANTIABORTIVE | 200892 | 1% | 100% | 1 | Search ANTIABORTIVE | Search ANTIABORTIVE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HUANG, Q , WANG, GJ , SUN, JG , A, JY , ZHA, WB , ZHANG, Y , ZHANG, JW , YAN, B , GU, SH , REN, HC , ET AL (2008) SIMULTANEOUS DETERMINATION OF GFA AND ITS ACTIVE METABOLITES IN HUMAN PLASMA BY LIQUID CHROMATOGRAPHY ELECTROSPRAY IONIZATION MASS SPECTROMETRY AND ITS APPLICATION TO PHARMACOKINETIC STUDIES.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 46. ISSUE 4. P. 728 -736 | 6 | 86% | 7 |
2 | GUO, W , SHI, XW , WANG, W , XIONG, C , LI, JX , (2014) PHARMACOKINETIC EVALUATION OF DIPFLUZINE AND ITS THREE METABOLITES IN RAT PLASMA USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY.JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. VOL. 947. ISSUE . P. 151 -155 | 4 | 100% | 0 |
3 | ZHANG, YL , WANG, L , CHEN, YJ , QING, C , (2013) ANTI-ANGIOGENIC ACTIVITY OF SALVICINE.PHARMACEUTICAL BIOLOGY. VOL. 51. ISSUE 8. P. 1061-1065 | 6 | 46% | 2 |
4 | WANG, YL , HE, RR , (1994) EFFECT OF DIPFLUZINE ON PLATELET-AGGREGATION AND THROMBUS FORMATION.ACTA PHARMACOLOGICA SINICA. VOL. 15. ISSUE 5. P. 443-446 | 5 | 100% | 2 |
5 | GUO, W , KONG, DZ , DU, YF , SHI, XW , WANG, W , WANG, YL , (2012) SIMULTANEOUS DETERMINATION OF A NOVEL DIPHENYLPIPERAZINE CALCIUM CHANNEL BLOCKER AND ITS FOUR METABOLITES IN RAT LIVER MICROSOMES BY LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY.PHARMACOLOGY. VOL. 89. ISSUE 3-4. P. 201-210 | 5 | 56% | 0 |
6 | MENG, LH , DING, J , (2007) SALVICINE, A NOVEL TOPOISOMERASE II INHIBITOR, EXERTS ITS POTENT ANTICANCER ACTIVITY BY ROS GENERATION.ACTA PHARMACOLOGICA SINICA. VOL. 28. ISSUE 9. P. 1460-1465 | 9 | 33% | 11 |
7 | LI, XT , WANG, GJ , WANG, SJ , SUN, JG , LIU, JH , (2005) PHARMACOKINETIES OF GUANFU BASE 1, AN ACTIVE METABOLITE OF GUANFU BASE A, IN RATS.BIOLOGICAL & PHARMACEUTICAL BULLETIN. VOL. 28. ISSUE 8. P. 1363 -1365 | 4 | 80% | 4 |
8 | CAI, Y , LU, J , MIAO, Z , LIN, L , DING, J , (2007) REACTIVE OXYGEN SPECIES CONTRIBUTE TO CELL KILLING AND P-GLYCOPROTEIN DOWNREGULATION BY SALVICINE IN MULTIDRUG RESISTANT K562/A02 CELLS.CANCER BIOLOGY & THERAPY. VOL. 6. ISSUE 11. P. 1794-1799 | 9 | 30% | 32 |
9 | A, JY , WANG, GJ , SUN, JG , GU, YC , WU, MS , LIU, JH , (2003) IDENTIFICATION OF PHASE I AND PHASE II METABOLITES OF GUANFU BASE A HYDROCHLORIDE IN HUMAN URINE.EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS. VOL. 28. ISSUE 4. P. 265-272 | 3 | 100% | 1 |
10 | A, JY , WANG, GJ , WU, MS , LIU, JH , (2002) IDENTIFICATION OF GUANFU BASE A HYDROCHLORIDE PHASE I AND PHASE II METABOLITES IN RAT BILE BY LIQUID CHROMATOGRAPHY MASS SPECTROMETRY.ACTA PHARMACOLOGICA SINICA. VOL. 23. ISSUE 11. P. 1045-1050 | 3 | 100% | 3 |
Classes with closest relation at Level 1 |